Biosimilar Launch Strategy in the U.S. and Emerging MarketsBy Seamus Cole and Dr Augustin NdiayeIn this article, Seamus will discuss past trends observed in the U.S. market and

Pharma and medical device companies have limited budgets to spend on consulting services. The smartest companies ensure their investments answer a key strategic need and directly support launch

Pharma and medical device companies have limited budgets to spend on consulting services. The smartest companies ensure their investments answer a key strategic need and directly support launch